Document:

Exhibit 10.9

 

ACKNOWLEDGEMENT
OF DEBT

 

KNOW
ALL MEN BY THESE PRESENCES,

 

THAT
BIOCRUDE TECHNOLOGIES, INC. (“Borrower”), a company organized under Canadian laws, bearing
the civic address of 1255 Phillips Square, suite 605, Montreal Quebec, Canada H3B 3G5, duly represented by the Chairman and CEO,
Mr. John Moukas, by corporate resolution, has borrowed from Mr. Boris Baran (“Lender”),
residing at 1008-5350 MacDonald Avenue, Montreal, Quebec, Canada H3X 2V2, the total sum of Forty Thousand Canadian Dollars
($40,000 CDN), in increments totaling to the said amount from February 2013 to March 2015, whereby the Borrower expressly renounces
the benefits of the “exceptio non numeratae
pecuniae” and confirms that he understands the meaning of this exception and the effect of its renunciation.

 

FOR
VALUE RECEIVED, the Borrower promises to pay to the Lender, the registered holder hereof, the principal sum of Forty
Thousand Canadian Dollars ($40,000 CDN), on or before December 31st, 2016 (the “Maturity
Date”), as determined by the Borrower, and to pay a one-time interest, on a compound basis, on the principal
sum outstanding at the Applicable Interest Rate of four percent (4.0%), accruing from March 15th, 2015, the date of
these negotiated and acknowledged presences, (the “Commencement
Date”), on the Maturity date (“Principal
Sum and Interest Payment Date”). Should the Borrower require an extension of an additional year for the
repayment of the borrowed funds and accrued interest thereof, from the Maturity Date, the Borrower shall request same from the
Lender, by way of written notice, no later than 15 days, prior to the Maturity Date of payment, and said request will not be refused
by Lender.

 

The
Borrower shall be entitled to pay large instalments or the full balance of capital and interest at any time prior to
the prescribed dates of payment. In any such event interest shall be calculated up to the date of payment.

 

IN
WITNESS WHEREOF, BioCrude Technologies, Inc. has executed this instrument on the 15th day of March,
2015, as a true act and deeded.

 

	Sealed, executed, and countersigned:	 
	 	 
	By: BioCrude Technologies, Inc.	 
	 	 
	/s/ Mr. John Moukas	 
	Mr. John Moukas; Chairman/CEO	 

 

Accepted, acknowledged, sealed and countersigned
this 15th day of March, 2015:

 

	By: Mr. Boris Baran	 
	 	 
	/s/ Mr. Boris Baran	 
	Mr. Boris BaranExhibit 10.10

 

ACKNOWLEDGEMENT
OF DEBT

 

KNOW ALL MEN BY THESE PRESENCES,

 

THAT
BIOCRUDE TECHNOLOGIES, INC. (“Borrower”), a company organized under Canadian laws, bearing
the civic address of 1255 Phillips Square, suite 605, Montreal Quebec, Canada H3B 3G5, duly represented by the Chairman and CEO,
Mr. John Moukas, by corporate resolution, has borrowed from Mr. Chaim (Joshua) Freund (“Lender”),
residing at 5784 Deom Avenue, Montreal, Quebec, Canada H3S 2N4, the total sum of Thirty Five Thousand Canadian Dollars
($35,000 CDN), in increments totaling to the said amount from January 2011 to July 2015, whereby the Borrower expressly renounces
the benefits of the “exceptio non numeratae
pecuniae” and confirms that he understands the meaning of this exception and the effect of its renunciation.

 

FOR
VALUE RECEIVED, the Borrower promises to pay to the Lender, the registered holder hereof, the principal sum
of Thirty Five Thousand Canadian Dollars ($35,000 CDN), on or before December 31st, 2016 (the “Maturity
Date”), as determined by the Borrower, and to pay a one-time interest, on a compound basis, on the principal
sum outstanding at the Applicable Interest Rate of four percent (4.0%), accruing from March 15th, 2016, the date of
these negotiated and acknowledged presences, (the “Commencement
Date”), on the Maturity date (“Principal
Sum and Interest Payment Date”). Should the Borrower require an extension of an additional year for the
repayment of the borrowed funds and accrued interest thereof, from the Maturity Date, the Borrower shall request same from the
Lender, by way of written notice, no later than 15 days, prior to the Maturity Date of payment, and said request will not be refused
by Lender.

 

The
Borrower shall be entitled to pay large instalments or the full balance of capital and interest at any time prior to
the prescribed dates of payment. In any such event interest shall be calculated up to the date of payment.

 

IN WITNESS WHEREOF, BioCrude Technologies, Inc. has executed this instrument on the 30th
day of July, 2015, as a true act and deeded.

 

	Sealed, executed, and countersigned:	 
	 	 
	By: BioCrude Technologies, Inc.	 
	 	 
	/s/ Mr.
    John Moukas	 
	Mr. John Moukas; Chairman/CEO	 

 

Accepted, acknowledged, sealed and countersigned
this 30th day of July, 2015:

 

	By: Mr. Chaim (Joshua) Freund	 
	 	 
	/s/ Mr. Chaim (Joshua) Freund	 
	Mr. Chaim (Joshua) FreundExhibit 10.11

 

ACKNOWLEDGEMENT
OF DEBT

 

KNOW ALL MEN BY
THESE PRESENCES,

 

THAT
BIOCRUDE TECHNOLOGIES, INC. (“Borrower”), a company organized under Canadian laws, bearing
the civic address of 1255 Phillips Square, suite 605, Montreal Quebec, Canada H3B 3G5, duly represented by the Chairman and CEO,
Mr. John Moukas, by corporate resolution, has borrowed from Mr. David Kirsh (“Lender”),
residing at 83 16th Avenue, Roxboro, Quebec, Canada H8Y 2Y2, the total sum of Eighty Thousand Canadian Dollars ($80,000
CDN), in increments totaling to the said amount from January 2011 to December 2015, whereby the Borrower expressly renounces the
benefits of the “exceptio non numeratae
pecuniae” and confirms that he understands the meaning of this exception and the effect of its renunciation.

 

FOR
VALUE RECEIVED, the Borrower promises to pay to the Lender, the registered holder hereof, the principal sum
of Eighty Thousand Canadian Dollars ($80,000 CDN), on or before December 31st, 2016 (the “Maturity
Date”), as determined by the Borrower, and to pay a one-time interest, on a compound basis, on the principal
sum outstanding at the Applicable Interest Rate of four percent (4.0%), accruing from March 15th, 2016, the date of
these negotiated and acknowledged presences, (the “Commencement
Date”), on the Maturity date (“Principal
Sum and Interest Payment Date”). Should the Borrower require an extension of an additional year for the
repayment of the borrowed funds and accrued interest thereof, from the Maturity Date, the Borrower shall request same from the
Lender, by way of written notice, no later than 15 days, prior to the Maturity Date of payment, and said request will not be refused
by Lender.

 

The
Borrower shall be entitled to pay large instalments or the full balance of capital and interest at any time prior to
the prescribed dates of payment. In any such event interest shall be calculated up to the date of payment.

 

IN
WITNESS WHEREOF, BioCrude Technologies, Inc. has executed this instrument on the 30th day of December,
2015, as a true act and deeded.

 

	Sealed, executed, and countersigned:	 
	 	 
	By: BioCrude Technologies, Inc.	 
	 	 
	/s/ Mr. John Moukas	 
	Mr. John Moukas; Chairman/CEO	 

 

Accepted,
acknowledged, sealed and countersigned this 30th day of December, 2015:

 

	By: Mr. David Kirsh	 
	 	 
	/s/ Mr. David Kirsh	 
	Mr. David KirshExhibit 10.4

 

LINE OF CREDIT RENEWAL AGREEMENT

Note #300915

This LINE OF CREDIT RENEWAL AGREEMENT (the "Agreement") is made this 7th day of September the year 2016 by and between:

THE BANKERS' BANK OF KENTUCKY

107 Progress Drive

P.O. Box 713

Frankfort, Ky. 40601    ("Lender")

And

PREMIER FINANCIAL BANCORP, INC.

2883 5th Avenue

Huntington, WV 25702 ("Borrower")

Whereas, Borrower is indebted to Lender as of the date hereof in the amount of $0.00 evidenced by a promissory note from Borrower to Lender in the original face amount of five million and 00/100 ($5,000.000.00), dated September 7, 2012 (the "Note") and then renewed on September 7, 2013, again on September 7, 2014 and then again on September 7, 2015 which is secured by 559,800 shares of Citizens Deposit Bank & Trust (Vanceburg, KY) capital stock.

Now, Therefore, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Lender and Borrower hereby agree as follows:

		1.	Amendment of Terms. Borrower and Lender desire to modify, renew and/or extend the Note by amending the terms thereof as follows, to be effective from and after the date hereof:

The Maturity Date of the Note, at which time all unpaid principal, accrued interest and other charges, fees and expenses shall be due and payable in full, shall be September 7, 2017.

Interest shall accrue on the outstanding principal balance of the Note, based on the actual number of days elapsed over an assumed year of 365 days, at the rate per annum equal to the JP Morgan Chase Co. Prime, adjusted daily, with a floor rate of 4.50%.

Borrower shall make payments on the Note as follows

Interest due quarterly beginning December 7, 2016.

Principal and all outstanding interest due and payable at maturity.

		2.	Acknowledgements and Waivers of Borrower. Borrower acknowledges that it has no defense to repayment of the Note in full and Borrower further acknowledges that it is not aware of any claim or cause of action it currently has against Lender. Borrower hereby fully, finally and forever releases Lender from and against any and all claims Borrower has or may have against Lender directly or indirectly arising out of the negotiation, closing or administration of the loan evidenced by the Note or directly or indirectly arising out of the negotiation or execution of this Agreement. Borrower further acknowledges and agrees that any other waivers of rights or defenses contained in the Note or any of the Security Documents shall remain in full force and effect and are hereby remade and affirmed as if set forth in full herein.

		3.	No Novation.  Lender and Borrower specifically agree that this Agreement represents a continuation and modification of credit previously extended and is not intended to constitute a novation. Except as expressly modified or amended herein, all of the terms and conditions of the Note, Loan Agreement, and any other Security Documents shall remain in full force and effect.

		4.	LATE CHARGE AND DEFAULT RATE OF INTEREST. IF ANY PAYMENT DUE UNDER THE NOTE, AS AMENDED HEREBY, IS NOT RECEIVED BY LENDER WITHIN 20 DAYS OF THE DATE IT IS DUE,THEN A LATE CHARGE OF 3.00% MAY BE CHARGED BY THE LENDER. UPON MATURITY OF THE NOTE, WHETHER BY ACCELERATION OR OTHERWISE, OR UPON THE OCCURRENCE OF AN EVENT OF DEFAULT UNDER THE NOTE, IN ADDITION TO ANY AND ALL OTHER REMEDIES TO WHICH THE LENDER MAY BE ENTITLED, THE APPLICABLE RATE OF INTEREST ON THIS NOTE SHALL BE INCREASED TO 5.00% PER ANNUM IN EXCESS OF THE RATE SET FORTH IN PARAGRAPH 1, ABOVE.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first set forth above

LENDER                             BANKERS' BANK OF KENTUCKY

By  /s/ John B. Clark                        

     John B. Clark, President

BORROWER                           PREMIER FINANCIAL BANCORP, INC.

By  /s/ Robert W. Walker                 

     Robert W. Walker, President and CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}]]